← Evidence map

ArticlePediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology2021

Safety and effectiveness of omalizumab for the treatment of chronic urticaria in pediatric patients.

Coco Dekkers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

12 papers cite it

2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33305439